Skip to main content

Workers wearing face masks amid concerns over the spread of the COVID-19 novel coronavirus sit in front of a closed market where circles are painted for people to maintain social distance in New Delhi, India, April 5, 2020.

Manish Swarup/The Associated Press

India is restricting the export of most diagnostic testing kits, as coronavirus cases in the South Asian nation topped 3,350 on Sunday despite a three-week nationwide lockdown to slow the spread of the respiratory disease.

India, which in recent weeks already banned the export of certain drugs, along with ventilators, masks and other protective gear needed by both patients and medical staff, issued the latest directive on Saturday.

The move comes even as U.S. President Donald Trump urged Prime Minister Narendra Modi in a phone call on Saturday, to release supplies of anti-malaria drug hydroxychloroquine, which is being tested as a possible treatment for patients with COVID-19 – the disease caused by the coronavirus.

Story continues below advertisement

“The two leaders agreed to remain in touch on the issue of global supply chains for critical pharmaceuticals and medical supplies and to ensure they continue to function as smoothly as possible during the global health crisis,” White House spokesman Judd Deere, said in a tweet on Saturday.

In a briefing note on the conversation, India said the two leaders “agreed to deploy the full strength of the India–U.S. partnership to resolutely and effectively combat COVID-19.”

BANGLADESH STIMULUS PLAN

The total number of confirmed COVID-19 cases in South Asia, home to roughly 1.9 billion people, climbed close to 7,000 on Sunday, even as the death toll from the respiratory disease in the Indian subcontinent rose to 143.

While the figures are relatively low in comparison with the United States, China, Italy and Spain, health experts fear that the spread of the pandemic in South Asia would overwhelm already weak public health systems in the region.

Bangladesh’s Prime Minister Sheikh Hasina unveiled a 727.50 billion taka (US$8.56 billion) stimulus package on Sunday to help the economy overcome the impact of the coronavirus outbreak.

“The amount is equivalent to 2.52 per cent of gross domestic product,” Ms. Hasina said in a televised address.

Reuters earlier this month reported that Bangladesh, the second-largest apparel producer after China, is set to lose roughly $6 billion in export revenue this financial year amid order cancellations from some of the world’s largest brands and retailers.

Story continues below advertisement

Bangladesh has so far recorded 88 cases of the disease that has so far claimed nine lives.

Following are government figures on the spread of the coronavirus in South Asia:

  • India has 3,374 cases, including 77 deaths
  • Pakistan has 2,880 cases, including 45 deaths
  • Afghanistan has 337 cases, including 7 deaths
  • Sri Lanka has 166 cases, including 5 deaths
  • Bangladesh has 88 cases, including 9 deaths
  • Maldives has 19 cases and no deaths
  • Nepal has nine cases and no deaths
  • Bhutan has five cases and no deaths

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you manage your health, your finances and your family life as Canada reopens.
Visit the hub

In the interests of public health and safety, our coronavirus news articles are free for anyone to access. However, The Globe depends on subscription revenue to support our journalism. If you are able, please subscribe to globeandmail.com. If you are already a subscriber, thank you for your support.

Your subscription helps The Globe and Mail provide readers with critical news at a critical time. Thank you for your continued support. We also hope you will share important coronavirus news articles with your friends and family. In the interest of public health and safety, all our coronavirus news articles are free for anyone to access.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies